# Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy

> **NCT01525888** · NA · COMPLETED · sponsor: **Soroka University Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Radiographic Contrast Agent Nephropathy

## Interventions

- **PROCEDURE:** stop angiotensin converting enzyme inhibitor or angiotensin receptor blocker (ACE-I/ARB)

## Key facts

- **NCT ID:** NCT01525888
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01525888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01525888, "Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01525888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*